BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, April 20, 2026
Home » Topics » Science

Science
Science RSS Feed RSS

BioWorld MedTech’s Oncology Extra for March 30, 2021

March 30, 2021
By Mark McCarty
Keeping you up to date on recent developments in oncology, including: NCI team devises method to recruit myeloid cells in pushback against cancer; Algorithm ranks cancer therapies for efficacy; New twist on quantum dots could revolutionize imaging.
Read More
Cancer cell and DNA

Gut microbial metabolites facilitate anticancer therapy

March 30, 2021
By John Fox
A study led by Chinese scientists at Tsinghua University in Beijing has demonstrated that the gut microbial metabolite butyrate can directly modulate the antitumor CD8 "killer" T-cell response and improve chemotherapy efficacy through ID2-dependent IL-12 signaling.
Read More

BioWorld MedTech’s Cardiology Extra for March 29, 2021

March 29, 2021
By Mark McCarty
Keeping you up to date on recent developments in cardiology, including: Algorithms can distinguish varying grades of pulmonary edema in heart failure; Cholesterol-independent heart disease risk gene; Study confirms role of smoking in CAD among Blacks.
Read More
Neurons and microglia
Bench Press

Antibodies could make things worse in neurodegeneration

March 29, 2021
By Anette Breindl
BioWorld looks at translational medicine, including: Myeloid cells differ in primary and recurrent glioblastoma.
Read More
Juvenile king penguin
Vultures and warthogs and bats, oh my!

Israeli startup goes bio(me)-prospecting in wild animals

March 26, 2021
By Anette Breindl
The animal world is full of species that can perform astonishing, and sometimes disgusting, feats. Take vultures, for example. “They eat this rotten meat that is full of pathogens and toxins, and they stay healthy,” Neta Raab told BioWorld. Raab is the co-founder and CEO of Wild Biotech Ltd., an Israeli startup that is seeking to understand gut microbiome contributions to these animal superpowers, and harness them for therapeutic use.
Read More

BioWorld MedTech’s Neurology Extra for March 26, 2021

March 26, 2021
By Andrea Applegate and Anette Breindl
Keeping you up to date on recent developments in neurology, including: New discovery improves DBS effects in Parkinson’s; Women accumulate Alzheimer’s-related protein faster; Brain cell alcohol metabolism affects behavior, addiction; Lipopolysaccharides induce neural repair sweet spot.
Read More
Astrocytes

Endocannabinoids act on astrocytes to prevent tremor

March 26, 2021
Investigators at the department of neuroscience at the faculty of health and medical sciences at the University of Copenhagen have discovered the mechanism of action of a synthetic cannabinoid derivative on spinal astrocytes for reduction of pathological tremors.
Read More

BioWorld MedTech’s Diagnostics Extra for March 25, 2021

March 25, 2021
By Meg Bryant
Keeping you up to date on recent developments in diagnostics, including: Review highlights differences in accuracy of COVID-19 rapid tests; Likelihood of disease from hidden genetic defects; Confocal PET enables color differentiation of PET tracers in preclinical imaging.
Read More
Juvenile king penguin
Vultures and warthogs and bats, oh my!

Israeli startup goes bio(me)-prospecting in wild animals

March 25, 2021
By Anette Breindl
The animal world is full of species that can perform astonishing, and sometimes disgusting, feats. Take vultures, for example. “They eat this rotten meat that is full of pathogens and toxins, and they stay healthy,” Neta Raab told BioWorld. Raab is the co-founder and CEO of Wild Biotech Ltd., an Israeli startup that is seeking to understand gut microbiome contributions to these animal superpowers, and harness them for therapeutic use.
Read More
Blue heart and data grid

Microvesicles promote infarct recovery in primates

March 25, 2021
By John Fox
A Chinese study has shown that small extracellular vesicles produced by microRNA-overexpressing mesenchymal stem cells improved cardiac function, reduced infarct size and promoted angiogenesis without arrhythmia in nonhuman primate models of myocardial infarction.
Read More
Previous 1 2 … 100 101 102 103 104 105 106 107 108 … 194 195 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 17, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • Novel caspase-2 inhibitor shows in vivo neuroprotective effects

    BioWorld Science
    Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing